These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 31479922)

  • 1. Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.
    Zhao Z; Ji M; Wang Q; He N; Li Y
    Mol Ther Nucleic Acids; 2019 Dec; 18():24-33. PubMed ID: 31479922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA UCA1 Mediates Resistance to Cisplatin by Regulating the miR-143/FOSL2-Signaling Pathway in Ovarian Cancer.
    Li Z; Niu H; Qin Q; Yang S; Wang Q; Yu C; Wei Z; Jin Z; Wang X; Yang A; Chen X
    Mol Ther Nucleic Acids; 2019 Sep; 17():92-101. PubMed ID: 31234009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CircRNA CDR1as/miR-641/HOXA9 pathway regulated stemness contributes to cisplatin resistance in non-small cell lung cancer (NSCLC).
    Zhao Y; Zheng R; Chen J; Ning D
    Cancer Cell Int; 2020; 20():289. PubMed ID: 32655321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNA CDR1as Alleviates Cisplatin-Based Chemoresistance by Suppressing MiR-1299 in Ovarian Cancer.
    Wu H; Zhao X; Wang J; Jiang X; Cheng Y; He Y; Sun L; Zhang G
    Front Genet; 2021; 12():815448. PubMed ID: 35154259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circular RNA Cdr1as sensitizes bladder cancer to cisplatin by upregulating APAF1 expression through miR-1270 inhibition.
    Yuan W; Zhou R; Wang J; Han J; Yang X; Yu H; Lu H; Zhang X; Li P; Tao J; Wei J; Lu Q; Yang H; Gu M
    Mol Oncol; 2019 Jul; 13(7):1559-1576. PubMed ID: 31131537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing CDR1as enhances the sensitivity of breast cancer cells to drug resistance by acting as a miR-7 sponge to down-regulate REGγ.
    Yang W; Yang X; Wang X; Gu J; Zhou D; Wang Y; Yin B; Guo J; Zhou M
    J Cell Mol Med; 2019 Aug; 23(8):4921-4932. PubMed ID: 31245927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA CDR1as acts as a sponge of miR-135b-5p to suppress ovarian cancer progression.
    Chen H; Mao M; Jiang J; Zhu D; Li P
    Onco Targets Ther; 2019; 12():3869-3879. PubMed ID: 31190886
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction Notice to: Circular RNA Cdr1as Upregulates SCAI to Suppress Cisplatin Resistance in Ovarian Cancer via miR-1270 Suppression.
    Zhao Z; Ji M; Wang Q; He N; Li Y
    Mol Ther Nucleic Acids; 2024 Jun; 35(2):102213. PubMed ID: 38784178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circular RNA CDR1as regulates osteoblastic differentiation of periodontal ligament stem cells via the miR-7/GDF5/SMAD and p38 MAPK signaling pathway.
    Li X; Zheng Y; Zheng Y; Huang Y; Zhang Y; Jia L; Li W
    Stem Cell Res Ther; 2018 Aug; 9(1):232. PubMed ID: 30170617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Circular RNA Cdr1as Promotes Myocardial Infarction by Mediating the Regulation of miR-7a on Its Target Genes Expression.
    Geng HH; Li R; Su YM; Xiao J; Pan M; Cai XX; Ji XP
    PLoS One; 2016; 11(3):e0151753. PubMed ID: 26998750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exendin-4 Reversed the PC12 Cell Damage Induced by circRNA CDR1as/miR-671/GSK3β Signaling Pathway.
    Quan H; Chen Q; Wang K; Wang Q; Lu M; Zhang Y; Qiang S; Xue S; Han L; Zhu H; Fan Q; Bao M; Xu W; Wang W
    J Mol Neurosci; 2021 Apr; 71(4):778-789. PubMed ID: 32889692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma.
    Li D; Tang Z; Gao Z; Shen P; Liu Z; Dang X
    Mol Cell Biol; 2020 Jul; 40(15):. PubMed ID: 32423991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of circular RNA CDR1as increases chemosensitivity of 5-FU-resistant BC cells through up-regulating miR-7.
    Yang W; Gu J; Wang X; Wang Y; Feng M; Zhou D; Guo J; Zhou M
    J Cell Mol Med; 2019 May; 23(5):3166-3177. PubMed ID: 30884120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CircRNA CDR1as specifically triggered low-dose Diosbulbin-B induced gastric cancer cell death by regulating miR-7-5p/REGγ axis.
    Li C; Li M; Xue Y
    Biomed Pharmacother; 2019 Dec; 120():109462. PubMed ID: 31542615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circRNA circARNT2 Suppressed the Sensitivity of Hepatocellular Carcinoma Cells to Cisplatin by Targeting the miR-155-5p/PDK1 Axis.
    Li Y; Zhang Y; Zhang S; Huang D; Li B; Liang G; Wu Y; Jiang Q; Li L; Lin C; Wei Z; Meng L
    Mol Ther Nucleic Acids; 2021 Mar; 23():244-254. PubMed ID: 33425483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Circular RNA CDR1as Regulates the Proliferation and Apoptosis of Human Cardiomyocytes Through the miR-135a/HMOX1 and miR-135b/HMOX1 Axes.
    Chen C; Shen H; Huang Q; Li Q
    Genet Test Mol Biomarkers; 2020 Sep; 24(9):537-548. PubMed ID: 32762552
    [No Abstract]   [Full Text] [Related]  

  • 17. Circular RNA CDR1as sponges miR-7-5p to enhance E2F3 stability and promote the growth of nasopharyngeal carcinoma.
    Zhong Q; Huang J; Wei J; Wu R
    Cancer Cell Int; 2019; 19():252. PubMed ID: 31582908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals.
    Zhang J; Hu H; Zhao Y; Zhao Y
    Cell Prolif; 2018 Dec; 51(6):e12521. PubMed ID: 30182381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CircRNA Cdr1as functions as a competitive endogenous RNA to promote hepatocellular carcinoma progression.
    Su Y; Lv X; Yin W; Zhou L; Hu Y; Zhou A; Qi F
    Aging (Albany NY); 2019 Oct; 11(19):8183-8203. PubMed ID: 31581132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Circular RNA Cdr1as Act as an Oncogene in Hepatocellular Carcinoma through Targeting miR-7 Expression.
    Yu L; Gong X; Sun L; Zhou Q; Lu B; Zhu L
    PLoS One; 2016; 11(7):e0158347. PubMed ID: 27391479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.